2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2024-10-1-0-93340Medicine (miscellaneous)<strong>The molecular profile people of different ages in &laquo;normal&raquo; and with dilated cardiomyopathy</strong><strong>The molecular profile people of different ages in &laquo;normal&raquo; and with dilated cardiomyopathy</strong>KravchenkoKirill P.KravchenkoKirill P.kirill.kravchenko.spb@yandex.ruPolyakovaVictoriya O.PolyakovaVictoriya O.vopol@yandex.ruMedvedevDmitrii S.MedvedevDmitrii S.mds@dsmedvedev.ruTrotsyukDina V.TrotsyukDina V.dinatrotsyuk@yandex.ru202410100

Background: Dilated cardiomyopathy (DCMP) is a cardiovascular pathology promising for consideration as a clinical model of premature aging of the body. According to the literature, sirtuins-1, 2, 3, 6; melatonin and its receptors (MT-1 and MT-2); markers of cellular aging (proteins p16, p21) and apoptosis (BAX) may have clinical significance for assessing premature aging of the body on the DCMP model. A comparative study of the expression of these molecules in people of different ages, depending on the presence of DCMP, has not been conducted before. The aim of the study: To identify and compare molecular profiles by the level of expression of the studied signaling molecules in the buccal epithelium and autopsy material of the myocardium in people of different ages with the absence of cardiovascular diseases and the presence of dilated cardiomyopathy. Materials and methods: A study of buccal epithelium (174 people) and autopsy material of myocardium (175 people) in patients aged 45-89 years for the expression of signaling molecules: sirtuins 1, 2, 3, 6, proteins p16, p21 and BAX, was conducted. Methods of immunocytochemical and immunohistochemical studies were used. Groups of middle, elderly and senile age with DCMP and without a history of cardiovascular pathology were identified. Results: Characteristic changes in the molecular profile (the level of the studied signaling molecules) in the buccal epithelium associated with age and the presence of DCMP were revealed: in middle&ndash;aged patients &ndash; a decrease in the expression of sirtuins 3 and 6 by 2,2-2,3 times, melatonin by 1,8 times and its receptors by 1,4-2,5 times; in elderly patients &ndash; a decrease in the expression of sirtuins 1 and 3 by 2,5 times; sirtuin 2 by 2,3 times; melatonin and its receptors by 1,4-1,8 times; in elderly patients &ndash; a decrease in the expression of sirtuins 3 and 6 by 3,0-4,7 times; sirtuins 1 and 2 by 6,7-7,3 times; melatonin by 2,8 times; MT-1 &ndash; 4,1 times and MT-2 &ndash; 23,7 times. An increase in the expression of p16 and BAX proteins by 0,6-0,8 times in the buccal epithelium has additional diagnostic information in the diagnosis of DCMP in individuals of different age groups. There is a correlation between changes in the expression of these molecules in the buccal epithelium and the autopsy material of the myocardium. Conclusion: Molecular profiles in people of different age groups, determined by the level of expression of the studied signaling molecules, significantly differ depending on the presence of DCMP. It is characteristic that the direction of changes in the buccal epithelium is similar to the corresponding molecular profile in the autopsy material of the myocardium

Background: Dilated cardiomyopathy (DCMP) is a cardiovascular pathology promising for consideration as a clinical model of premature aging of the body. According to the literature, sirtuins-1, 2, 3, 6; melatonin and its receptors (MT-1 and MT-2); markers of cellular aging (proteins p16, p21) and apoptosis (BAX) may have clinical significance for assessing premature aging of the body on the DCMP model. A comparative study of the expression of these molecules in people of different ages, depending on the presence of DCMP, has not been conducted before. The aim of the study: To identify and compare molecular profiles by the level of expression of the studied signaling molecules in the buccal epithelium and autopsy material of the myocardium in people of different ages with the absence of cardiovascular diseases and the presence of dilated cardiomyopathy. Materials and methods: A study of buccal epithelium (174 people) and autopsy material of myocardium (175 people) in patients aged 45-89 years for the expression of signaling molecules: sirtuins 1, 2, 3, 6, proteins p16, p21 and BAX, was conducted. Methods of immunocytochemical and immunohistochemical studies were used. Groups of middle, elderly and senile age with DCMP and without a history of cardiovascular pathology were identified. Results: Characteristic changes in the molecular profile (the level of the studied signaling molecules) in the buccal epithelium associated with age and the presence of DCMP were revealed: in middle&ndash;aged patients &ndash; a decrease in the expression of sirtuins 3 and 6 by 2,2-2,3 times, melatonin by 1,8 times and its receptors by 1,4-2,5 times; in elderly patients &ndash; a decrease in the expression of sirtuins 1 and 3 by 2,5 times; sirtuin 2 by 2,3 times; melatonin and its receptors by 1,4-1,8 times; in elderly patients &ndash; a decrease in the expression of sirtuins 3 and 6 by 3,0-4,7 times; sirtuins 1 and 2 by 6,7-7,3 times; melatonin by 2,8 times; MT-1 &ndash; 4,1 times and MT-2 &ndash; 23,7 times. An increase in the expression of p16 and BAX proteins by 0,6-0,8 times in the buccal epithelium has additional diagnostic information in the diagnosis of DCMP in individuals of different age groups. There is a correlation between changes in the expression of these molecules in the buccal epithelium and the autopsy material of the myocardium. Conclusion: Molecular profiles in people of different age groups, determined by the level of expression of the studied signaling molecules, significantly differ depending on the presence of DCMP. It is characteristic that the direction of changes in the buccal epithelium is similar to the corresponding molecular profile in the autopsy material of the myocardium

dilated cardiomyopathysirtuinmelatoninBAXage-related changespremature agingdilated cardiomyopathysirtuinmelatoninBAXage-related changespremature agingСписок литературыGuo J, Huang X, Dou L, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduction and Targeted Therapy. 2022;7:391. DOI: https://doi.org/10.1038/s41392-022-01251-0Orphanou N, Papatheodorou E, Anastasakis A. Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments. Heart Failure Reviews. 2022;27(4):1173-1191. DOI: https://doi.org/10.1007/s10741-021-10139-0Alaeva EN, Narusov OYu, Tereshchenko SN, et al. Diagnosis and treatment of dilated cardiomyopathy in everyday clinical practice (data from the first Russian registry for dilated cardiomyopathy). Cardiological Bulletin. 2014;2:54-61. Russian.D&#39;Onofrio N, Servillo L, Balestrieri ML. SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection. Antioxidants and Redox Signaling. 2018;28(8):711-732. DOI: https://doi.org/10.1089/ars.2017.7178Wang Y, Yang J, Hong T, et al. SIRT2: Controversy and multiple roles in disease and physiology. Ageing Research Reviews. 2019;55:100961. DOI: https://doi.org/10.1016/j.arr.2019.100961Sun W, Liu C, Chen Q, et al. SIRT3: A New Regulator of Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity. 2018;2018:7293861. DOI: https://doi.org/10.1155/2018/7293861Oishi A, Cecon E, Jockers R. Melatonin Receptor Signaling: Impact of Receptor Oligomerization on Receptor Function. International Review of Cell and Molecular Biology. 2018;338:59-77. DOI: https://doi.org/10.1016/bs.ircmb.2018.02.002Huang S, Xu M, Liu L, et al. Autophagy is involved in the protective effect of p21 on LPS-induced cardiac dysfunction. Cell Death and Disease. 2020;11(7):554. DOI: https://doi.org/10.1038/s41419-020-02765-7Pe&ntilde;a-Blanco A, Garc&iacute;a-S&aacute;ez AJ. Bax, Bak and beyond - mitochondrial performance in apoptosis. The FEBS journal. 2018;285(3):416-431. DOI: https://doi.org/10.1111/febs.14186Sarikhani M, Maity S, Mishra S, et al. SIRT2 deacetylase represses NFAT transcription factor to maintain cardiac homeostasis. Journal of Biological Chemistry. 2018;293(14):5281-5294. DOI: https://doi.org/10.1074/jbc.RA117.000915Grootaert MOJ, Finigan A, Figg NL, et al. SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis. Circulation Research. 2021;128(4):474-491. DOI: https://doi.org/10.1161/CIRCRESAHA.120.318353Mohammadi-Sartang M, Ghorbani M, Mazloom Z. Effects of melatonin supplementation on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition. 2018;37(6 Pt A):1943-1954. DOI: https://doi.org/10.1016/j.clnu.2017.11.003Kurhaluk N, Tkachenko H. Melatonin and alcohol-related disorders. Chronobiology International. 2020;37(6):781-803. DOI: https://doi.org/10.1080/07420528.2020.1761372Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of aging. Journal of Clinical Investigation. 2004;114(9):1299-1307. DOI: https://doi.org/10.1172/JCI22475.Spitz AZ, Gavathiotis E. Physiological and pharmacological modulation of BAX. Trends in Pharmacological Sciences. 2022;43(3):206-220. DOI: https://doi.org/10.1016/j.tips.2021.11.001Taneja A, Ravi V, Hong JY, et al. Emerging roles of Sirtuin 2 in cardiovascular diseases. FASEB Journal. 2021;35(10):e21841. DOI: https://doi.org/10.1096/fj.202100490RHan D, Wang Y, Chen J, et al. Activation of melatonin receptor 2 but not melatonin receptor 1 mediates melatonin-conferred cardioprotection against myocardial ischemia/reperfusion injury. Journal of Pineal Research. 2019;67(1):e12571. DOI: https://doi.org/10.1111/jpi.12571Gu W, Cheng Y, Wang S, et al. PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2. Cardiovascular Toxicology. 2021;21(6):451-461. DOI: https://doi.org/10.1007/s12012-021-09639-0Wu B, You S, Qian H, et al. The role of SIRT2 in vascular-related and heart-related diseases: A review. Journal of Cellular and Molecular Medicine. 2021;25(14):6470-6478. DOI: https://doi.org/10.1111/jcmm.16618Zhao L, Tao X, Qi Y, et al. Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. Redox Biology. 2018;16:189-198. DOI: https://doi.org/10.1016/j.redox.2018.02.026Caporizzo MA, Prosser BL. The microtubule cytoskeleton in cardiac mechanics and heart failure. Nature Reviews Cardiology. 2022;19(6):364-378. DOI: https://doi.org/10.1038/s41569-022-00692-yLi Z, Zhang Z, Ren Y, et al. Aging and age-related diseases: from mechanisms to therapeutic strategies. Biogerontology. 2021;22(2):165-187. DOI: https://doi.org/10.1007/s10522-021-09910-5Tobeiha M, Jafari A, Fadaei S, et al. Evidence for the Benefits of Melatonin in Cardiovascular Disease. Frontiers in Cardiovascular Medicine. 2022;9:888319. DOI: https://doi.org/10.3389/fcvm.2022.888319Yan G, Yu L, Jiang S, et al. Melatonin antagonizes oxidative stress-induced mitochondrial dysfunction in retinal pigmented epithelium cells via melatonin receptor 1 (MT1). Journal of Toxicological Sciences. 2018;43(11):659-669. DOI: https://doi.org/10.2131/jts.43.659